Lacosamide 10 MG/ML Oral Solution — RxCUI 993856
RxNorm drug concept · Semantic clinical drug
RxCUI 993856
Semantic clinical drug · SCD
● Current RxNorm concept 31 FDA products
57 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI993856
Official nameLacosamide 10 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslacosamide 10 MG per 1 ML Oral Solution; lacosamide 10 MG in 1 mL Oral Solution
FDA products mapped31
Package NDCs mapped57
Reported Medicaid activity (SDUD)176,178 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Lacosamide: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats partial-onset seizures, and it is also used as add-on treatment for primary generalized tonic-clonic seizures. Which age groups it covers depends on the product, so your...
- Tablets and oral solution are usually taken twice a day, with or without food. Motpoly XR is a once-daily capsule that you swallow whole, without opening, chewing or crushing. Foll...
- Dizziness is the big one, along with headache, double or blurry vision, nausea, sleepiness and balance trouble. These are most noticeable when starting or raising the dose. Tell yo...
- Call right away for fainting, a very slow or irregular heartbeat, or new or worsening depression or suicidal thoughts. Also call for fever with rash or swelling, which can be a ser...
🕸️ Concept Web — How Lacosamide 10 MG/ML Oral Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Lacosamide 10 MG/ML Oral Solution
RxCUI 993856 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Lacosamide
623400IN
-
Lacosamide
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Vimpat
809979BN
-
Vimpat
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Lacosamide Oral Solution
993855SCDF -
Lacosamide Oral Liquid Product
1162528SCDG -
Lacosamide Oral Product
1162529SCDG -
Lacosamide Oral Solution [Vimpat]
995155SBDF -
Vimpat Oral Liquid Product
1186609SBDG -
Vimpat Oral Product
1186610SBDG -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Lacosamide Oral Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Lacosamide 10 MG/ML
809972SCDC -
Lacosamide 10 MG/ML Oral Solution [Vimpat]
995156SBD -
Lacosamide 10 MG/ML [Vimpat]
809983SBDC
-
Lacosamide 10 MG/ML
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Lacosamide 10 MG/ML
SCDC · 809972 -
Lacosamide Oral Solution
SCDF · 993855 -
Lacosamide Oral Liquid Product
SCDG · 1162528 -
Lacosamide Oral Product
SCDG · 1162529
Brand-Name Concepts
-
Lacosamide 10 MG/ML Oral Solution [Vimpat]
SBD · 995156 -
Lacosamide 10 MG/ML [Vimpat]
SBDC · 809983 -
Lacosamide Oral Solution [Vimpat]
SBDF · 995155 -
Vimpat Oral Liquid Product
SBDG · 1186609 -
Vimpat Oral Product
SBDG · 1186610 -
Vimpat
BN · 809979
📦 FDA Products & Package NDCs
31 products · 57 package NDCs
57 package NDCs map to RxCUI 993856 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00121-1012-95 | 1 TRAY in 1 CASE (0121-1012-95) / 10 CUP, UNIT-DOSE in 1 TR... | Lacosamide | PAI Holdings, LLC dba PAI Pharma | 2023-04-28 |
| 00121-2024-95 | 1 TRAY in 1 TRAY (0121-2024-95) / 10 CUP, UNIT-DOSE in 1 TR... | Lacosamide | PAI Holdings, LLC dba PAI Pharma | 2023-04-28 |
| 00121-3036-95 | 1 TRAY in 1 CASE (0121-3036-95) / 10 CUP, UNIT-DOSE in 1 TR... | Lacosamide | PAI Holdings, LLC dba PAI Pharma | 2023-06-30 |
| 00121-4048-95 | 1 TRAY in 1 CASE (0121-4048-95) / 10 CUP, UNIT-DOSE in 1 TR... | Lacosamide | PAI Holdings, LLC dba PAI Pharma | 2022-08-26 |
| 00131-1810-67 | 10 VIAL, GLASS in 1 CARTON (0131-1810-67) / 20 mL in 1 VIAL... | Vimpat | UCB, Inc. | 2009-05-26 |
| 00131-2477-35 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0131-2477-35) | Vimpat | UCB, Inc. | 2009-05-26 |
| 00131-2477-60 | 6 BLISTER PACK in 1 CARTON (0131-2477-60) / 10 TABLET, FILM... | Vimpat | UCB, Inc. | 2009-05-26 |
| 00131-2477-99 | 1 BLISTER PACK in 1 CARTON (0131-2477-99) / 14 TABLET, FILM... | Vimpat | UCB, Inc. | 2009-05-26 |
| 00131-2478-35 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0131-2478-35) | Vimpat | UCB, Inc. | 2009-05-26 |
| 00131-2478-60 | 6 BLISTER PACK in 1 CARTON (0131-2478-60) / 10 TABLET, FILM... | Vimpat | UCB, Inc. | 2009-05-26 |
| 00131-2478-99 | 1 BLISTER PACK in 1 CARTON (0131-2478-99) / 14 TABLET, FILM... | Vimpat | UCB, Inc. | 2009-05-26 |
| 00131-2479-35 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0131-2479-35) | Vimpat | UCB, Inc. | 2009-05-26 |
| 00131-2479-60 | 6 BLISTER PACK in 1 CARTON (0131-2479-60) / 10 TABLET, FILM... | Vimpat | UCB, Inc. | 2009-05-26 |
| 00131-2479-99 | 1 BLISTER PACK in 1 CARTON (0131-2479-99) / 14 TABLET, FILM... | Vimpat | UCB, Inc. | 2009-05-26 |
| 00131-2480-35 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0131-2480-35) | Vimpat | UCB, Inc. | 2009-05-26 |
| 00131-2480-60 | 6 BLISTER PACK in 1 CARTON (0131-2480-60) / 10 TABLET, FILM... | Vimpat | UCB, Inc. | 2009-05-26 |
| 00131-2480-99 | 1 BLISTER PACK in 1 CARTON (0131-2480-99) / 14 TABLET, FILM... | Vimpat | UCB, Inc. | 2009-05-26 |
| 00131-5410-72 | 200 mL in 1 BOTTLE, GLASS (0131-5410-72) | Vimpat | UCB, Inc. | 2010-04-20 |
| 00904-7463-68 | 1 TRAY in 1 CASE (0904-7463-68) / 10 CUP, UNIT-DOSE in 1 TR... | Lacosamide | Major Pharmaceuticals | 2023-04-28 |
| 00904-7464-64 | 1 TRAY in 1 CASE (0904-7464-64) / 10 CUP, UNIT-DOSE in 1 TR... | Lacosamide | Major Pharmaceuticals | 2024-06-26 |
| 31722-0627-26 | 1 BOTTLE in 1 CARTON (31722-627-26) / 200 mL in 1 BOTTLE | Lacosamide | Camber Pharmaceuticals, Inc. | 2022-05-31 |
| 31722-0627-46 | 1 BOTTLE in 1 CARTON (31722-627-46) / 465 mL in 1 BOTTLE | Lacosamide | Camber Pharmaceuticals, Inc. | 2022-05-31 |
| 59651-0016-02 | 200 mL in 1 BOTTLE, PLASTIC (59651-016-02) | Lacosamide | Aurobindo Pharma Limited | 2024-01-24 |
| 59651-0016-46 | 465 mL in 1 BOTTLE, PLASTIC (59651-016-46) | Lacosamide | Aurobindo Pharma Limited | 2024-01-24 |
| 60687-0847-54 | 1 TRAY in 1 CASE (60687-847-54) / 10 CUP, UNIT-DOSE in 1 TR... | Lacosamide | American Health Packaging | 2025-01-24 |
| 60687-0847-55 | 1 TRAY in 1 CASE (60687-847-55) / 10 CUP, UNIT-DOSE in 1 TR... | Lacosamide | American Health Packaging | 2025-01-13 |
| 60687-0847-82 | 1 TRAY in 1 CASE (60687-847-82) / 10 CUP, UNIT-DOSE in 1 TR... | Lacosamide | American Health Packaging | 2025-01-09 |
| 62135-0885-22 | 200 mL in 1 BOTTLE (62135-885-22) | Lacosamide Oral Solution | Chartwell RX, LLC | 2024-11-27 |
| 62135-0885-23 | 2 TRAY in 1 BOX (62135-885-23) / 10 CUP in 1 TRAY / 10 mL i... | Lacosamide Oral Solution | Chartwell RX, LLC | 2025-02-10 |
| 62135-0885-24 | 2 TRAY in 1 BOX (62135-885-24) / 10 CUP in 1 TRAY / 5 mL in... | Lacosamide Oral Solution | Chartwell RX, LLC | 2025-02-10 |
| 67877-0732-95 | 200 mL in 1 BOTTLE (67877-732-95) | Lacosamide Oral Solution | Ascend Laboratories, LLC | 2022-05-20 |
| 67877-0732-97 | 465 mL in 1 BOTTLE (67877-732-97) | Lacosamide Oral Solution | Ascend Laboratories, LLC | 2022-05-20 |
| 68094-0076-62 | 3 TRAY in 1 CASE (68094-076-62) / 10 CUP, UNIT-DOSE in 1 TR... | LACOSAMIDE | Precision Dose, Inc. | 2025-09-22 |
| 68094-0176-62 | 3 TRAY in 1 CASE (68094-176-62) / 10 CUP, UNIT-DOSE in 1 TR... | LACOSAMIDE | Precision Dose, Inc. | 2025-09-22 |
| 68462-0940-86 | 200 mL in 1 BOTTLE, PLASTIC (68462-940-86) | Lacosamide | Glenmark Pharmaceuticals Limited | 2024-09-30 |
| 68999-0885-23 | 2 TRAY in 1 BOX (68999-885-23) / 10 CUP in 1 TRAY / 10 mL i... | Lacosamide Oral Solution | Chartwell Governmental & Specialty RX, LLC. | 2026-01-14 |
| 68999-0885-24 | 2 TRAY in 1 BOX (68999-885-24) / 10 CUP in 1 TRAY / 5 mL in... | Lacosamide Oral Solution | Chartwell Governmental & Specialty RX, LLC. | 2026-01-14 |
| 69315-0318-20 | 200 mL in 1 BOTTLE, PLASTIC (69315-318-20) | Lacosamide | Leading Pharma, LLC | 2023-07-25 |
| 69315-0318-46 | 465 mL in 1 BOTTLE, PLASTIC (69315-318-46) | Lacosamide | Leading Pharma, LLC | 2023-07-25 |
| 70954-0488-10 | 200 mL in 1 BOTTLE, PLASTIC (70954-488-10) | Lacosamide | ANI Pharmaceuticals, Inc. | 2022-08-26 |
| 71921-0411-71 | 1 BOTTLE in 1 CARTON (71921-411-71) / 200 mL in 1 BOTTLE | Lacosamide Oral Solution | Florida Pharmaceutical Products, LLC | 2026-01-30 |
| 72162-2637-02 | 200 mL in 1 BOTTLE, PLASTIC (72162-2637-2) | Lacosamide | Bryant Ranch Prepack | 2026-05-06 |
| 72205-0034-50 | 1 TRAY in 1 BOX (72205-034-50) / 10 CUP, UNIT-DOSE in 1 TRA... | Lacosamide | Novadoz Pharmaceuticals LLC | 2024-12-12 |
| 72205-0034-74 | 200 mL in 1 BOTTLE, PLASTIC (72205-034-74) | Lacosamide | Novadoz Pharmaceuticals LLC | 2023-12-29 |
| 72205-0034-75 | 465 mL in 1 BOTTLE, PLASTIC (72205-034-75) | Lacosamide | Novadoz Pharmaceuticals LLC | 2023-12-29 |
| 72205-0034-91 | 1 TRAY in 1 BOX (72205-034-91) / 10 CUP, UNIT-DOSE in 1 TRA... | Lacosamide | Novadoz Pharmaceuticals LLC | 2024-12-12 |
| 72205-0034-93 | 1 TRAY in 1 BOX (72205-034-93) / 10 CUP, UNIT-DOSE in 1 TRA... | Lacosamide | Novadoz Pharmaceuticals LLC | 2024-12-12 |
| 72205-0034-94 | 1 TRAY in 1 BOX (72205-034-94) / 10 CUP, UNIT-DOSE in 1 TRA... | Lacosamide | Novadoz Pharmaceuticals LLC | 2024-12-12 |
| 72603-0305-01 | 200 mL in 1 BOTTLE, PLASTIC (72603-305-01) | Lacosamide | NorthStar Rx LLC | 2024-06-01 |
| 81033-0427-14 | 10 CUP, UNIT-DOSE in 1 CARTON (81033-427-14) / 5 mL in 1 CU... | Lacosamide Oral Solution | Kesin Pharmaceutical Corporation | 2025-08-05 |
Observed labelers:
UCB, Inc. (14) ·
Novadoz Pharmaceuticals LLC (6) ·
Kesin Pharmaceutical Corporation (4) ·
PAI Holdings, LLC dba PAI Pharma (4) ·
American Health Packaging (3) ·
Chartwell RX, LLC (3)
· +15 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.